Vishal Duggal
Company: Genentech
Job title: Associate Medical Director
Seminars:
Deciphering the Precise Role of Complement Activation in IgA Nephropathy to Develop Therapeutic Inhibitors 11:45 am
Discussing the role of the complement cascade in the pathogenesis of IgA nephropathy Review results of the Phase II trial of RO7434656, an antisense oligonucleotide targeting complement Providing an overview of the Phase III IMAgINATION trial of RO7434656 in patients with IgA nephropathyRead more
day: Pre-Conference Seminar Day
Panel Discussion | Novel Targets in Development for IgA Nephropathy: Where are the Current Late Phase Trials Heading? 11:00 am
From complement to APRIL to ETA: what targets are currently in development and looking most promising? Exploring new treatment possibilities with combinational targeting Exploring the current thinking on IgA pathogenesis to direct priorities for future target developmentRead more
day: Pre-Conference Seminar Day